CanaQuest Medical Corp.
CANQF · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.11 | -0.05 | 0.17 |
| FCF Yield | -12.88% | -13.21% | -3.29% | -2.71% |
| EV / EBITDA | -1.92 | -5.68 | -11.42 | -15.26 |
| Quality | ||||
| ROIC | 186.56% | 230.68% | 180.86% | 46.90% |
| Gross Margin | 39.85% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.20 | 4.03 | 0.32 | 0.34 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | – |
| Free Cash Flow Growth | 44.35% | -140.99% | -187.17% | -106.48% |
| Safety | ||||
| Net Debt / EBITDA | -0.29 | -0.82 | -0.58 | -1.08 |
| Interest Coverage | -27.20 | -18.37 | -30.18 | -15.74 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 250.38 | 0.00 | 0.00 | 2,788.17 |